Tango Therapeutics, Inc. · NASDAQ:TNGX

Crystal Adam sold 27,000 Tango Therapeutics, Inc. shares (Form 4)

Traded Jun 1, 2026 · Filed Jun 3, 2026

On Jun 1, 2026, Crystal Adam (President, R&D) sold 27,000 Tango Therapeutics, Inc. shares at an average US$22.88 for US$618K under a trading plan, leaving 115,743 shares. Filed Jun 3, 2026 (Form 4).

Sold
27,000 shares
Price
US$22.88 average (US$22.25 to US$23.06)
Value
US$618K
Holding after
115,743 shares
Trading plan
Yes (Made under a plan set in advance)
Role
President, R&D

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 1, 2026Common StockOption exercise27,000US$5.20142,743Direct
Jun 1, 2026Common StockSale6,140US$22.25136,603Direct
Jun 1, 2026Common StockSale20,860US$23.06115,743Direct

Source

View original at SEC

Related